Quantification of Mineralized Bone Response to Prostate Cancer by Noninvasive In Vivo μCT and Non-Destructive Ex Vivo μCT and DXA in a Mouse Model
Open Access
- 29 March 2010
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 5 (3), e9854
- https://doi.org/10.1371/journal.pone.0009854
Abstract
To compare nondestructive in vivo and ex vivo micro-computed tomography (μCT) and ex vivo dual-energy-X-ray-absorptiometry (DXA) in characterizing mineralized cortical and trabecular bone response to prostate cancer involving the skeleton in a mouse model. In vivo μCT was performed before and 10 weeks after implantation of human prostate cancer cells (MDA-PCa-2b) or vehicle into SCID mouse femora. After resection, femora were imaged by nondestructive ex vivo specimen μCT at three voxel sizes (31 µ, 16 µ, 8 µ) and DXA, and then sectioned for histomorphometric analysis of mineralized bone. Bone mineral density (BMD), trabecular parameters (number, TbN; separation, TbSp; thickness, TbTh) and mineralized bone volume/total bone volume (BV/TV) were compared and correlated among imaging methods and histomorphometry. Statistical tests were considered significant if P<0.05. Ten weeks post inoculation, diaphyseal BMD increased in the femur with tumor compared to the opposite femur by all modalities (p<0.005, n = 11). Diaphyseal BMD by in vivo μCT correlated with ex vivo 31 and 16 µm μCT and histomorphometry BV/TV (r = 0.91–0.94, P<0.001, n = 11). DXA BMD correlated less with bone histomorphometry (r = 0.73, P<0.001, n = 11) and DXA did not distinguish trabeculae from cortex. By in vivo and ex vivo μCT, trabecular BMD decreased (P<0.05, n = 11) as opposed to the cortex. Unlike BMD, trabecular morphologic parameters were threshold-dependent and when using “fixed-optimal-thresholds,” all except TbTh demonstrated trabecular loss with tumor and correlated with histomorphometry (r = 0.73–0.90, P<0.05, n = 11). Prostate cancer involving the skeleton can elicit a host bone response that differentially affects the cortex compared to trabeculae and that can be quantified noninvasively in vivo and nondestructively ex vivo.Keywords
This publication has 34 references indexed in Scilit:
- Androgen receptor is a tumor suppressor and proliferator in prostate cancerProceedings of the National Academy of Sciences, 2008
- Cancer gene therapy using mesenchymal stem cells expressing interferon-β in a mouse prostate cancer lung metastasis modelGene Therapy, 2008
- Volumetric Quantitative CT of the Spine and Hip Derived from Contrast-Enhanced MDCT: Conversion FactorsAmerican Journal of Roentgenology, 2007
- A Prostate-Specific Antigen-Activated Channel-Forming Toxin as Therapy for Prostatic DiseaseJNCI Journal of the National Cancer Institute, 2007
- In vivo imaging of prostate cancer involving bone in a mouse modelThe Prostate, 2006
- Spiculated periosteal response induced by intraosseous injection of 22Rv1 prostate cancer cells resembles subset of bone metastases in prostate cancer patientsThe Prostate, 2005
- Ovariectomy-Induced Bone Loss Varies Among Inbred Strains of MiceJournal of Bone and Mineral Research, 2005
- Trabecular thickness measurement in cancellous bones: postmortem rat studies with the zoom-in micro-tomography techniquePhysiological Measurement, 2005
- Intraosseous growth of human prostate cancer in implanted adult human bone: Relationship of prostate cancer cells to osteoclasts in osteoblastic metastatic lesionsThe Prostate, 2003
- The direct examination of three-dimensional bone architecture in vitro by computed tomographyJournal of Bone and Mineral Research, 1989